SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-230348
Filing Date
2024-10-01
Accepted
2024-10-01 17:22:27
Documents
14
Effectiveness Date
2024-10-01

Document Format Files

Seq Description Document Type Size
1 S-3ASR d893437ds3asr.htm S-3ASR 374444
2 EX-1.2 d893437dex12.htm EX-1.2 230854
3 EX-4.3 d893437dex43.htm EX-4.3 287026
4 EX-5.1 d893437dex51.htm EX-5.1 22802
5 EX-5.2 d893437dex52.htm EX-5.2 12069
6 EX-23.2 d893437dex232.htm EX-23.2 1702
7 EX-FILING FEES d893437dexfilingfees.htm EX-FILING FEES 37137
8 GRAPHIC g893437dsp115.jpg GRAPHIC 5846
9 GRAPHIC g893437dsp116.jpg GRAPHIC 3564
10 GRAPHIC g893437dsp119.jpg GRAPHIC 10973
11 GRAPHIC g893437g04k04.jpg GRAPHIC 51411
12 GRAPHIC g893437g1001104429148.jpg GRAPHIC 1788
13 GRAPHIC g893437g35k35.jpg GRAPHIC 45396
14 GRAPHIC g893437g40k40.jpg GRAPHIC 191819
  Complete submission text file 0001193125-24-230348.txt   1388518
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-282460 | Film No.: 241344451
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)